ASO Author Reflections: Neoadjuvant Systemic Therapy and Nodal Management in cT1-2 N0 Triple-Negative Breast Cancer

被引：2
|
作者：
Cortina, Chandler S. [1 ,2 ]
Rogers, Christine C. [1 ]
Teshome, Mediget [3 ]
机构：
[1] Med Coll Wisconsin, Dept Surg, Div Surg Oncol, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2024年 / 31卷 / 05期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1245/s10434-024-15020-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：3196 / 3197
页数：2
相关论文
共 50 条
  • [41] Clinical Outcomes Following Breast-Conserving Therapy Versus Mastectomy for T1-2N0 Triple-Negative Breast Cancer
    Dai, C.
    Miller, J. A.
    Shah, C. S.
    Tendulkar, R. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E3 - E3
  • [42] Pathologic nodal positivity in patients with cT1-2 cN0 HER2+breast cancer treated with upfront surgery or neoadjuvant anti-HER2-based therapy
    Martinez Saez, O.
    Hernando Melia, C.
    Rey, M.
    Chic, N.
    Martinez, M. T. M.
    Cebrecos, I.
    Bermejo De Las Heras, B.
    Bargallo, X.
    Burgues, O.
    Ganau, S.
    Ubeda, B.
    Molla, M.
    Vidal-Siscart, S.
    Sanfeliu Torres, E.
    Gonzalez-Farre, B.
    Vidal, M.
    Adamo, B.
    Munoz, M.
    Prat, A.
    Cejalvo Andujar, J. M.
    ANNALS OF ONCOLOGY, 2022, 33 : S174 - S174
  • [43] ASO Author Reflections: Changes in Use of Neoadjuvant Chemotherapy Over Time—Highest Rates of Use Now in Triple-Negative and HER2+ Disease
    Brittany L. Murphy
    Judy C. Boughey
    Annals of Surgical Oncology, 2018, 25 : 695 - 696
  • [44] Pathologic nodal positivity in patients with cT1-2 cN0 HER2+breast cancer treated with upfront surgery or neoadjuvant anti-HER2-based therapy
    不详
    ANNALS OF ONCOLOGY, 2022, 33 : S174 - S174
  • [45] Prognostic Role of Adjuvant Chemotherapy in Node-Negative (N0), Triple-Negative (TN), Medullary Breast Cancer (MBC) in the Korean Population
    Lim, SeungTaek
    Park, Se Ho
    Park, Heong Kyu
    Hur, Min Hee
    Oh, Se Jeong
    Suh, Young Jin
    PLOS ONE, 2015, 10 (11):
  • [46] Optimization of Neoadjuvant Therapy for Early-Stage Triple-Negative and HER2+Breast Cancer
    Phadke, Sneha
    CURRENT ONCOLOGY REPORTS, 2022, 24 (12) : 1779 - 1789
  • [47] Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple-negative breast cancer
    Adrada, Beatriz E.
    Candelaria, Rosalind
    Moulder, Stacy
    Thompson, Alastair
    Wei, Peng
    Whitman, Gary J.
    Valero, Vicente
    Litton, Jennifer K.
    Santiago, Lumarie
    Scoggins, Marion E.
    Moseley, Tanya W.
    White, Jason B.
    Ravenberg, Elizabeth E.
    Yang, Wei T.
    Rauch, Gaiane M.
    CANCER, 2021, 127 (16) : 2880 - 2887
  • [48] Optimization of Neoadjuvant Therapy for Early-Stage Triple-Negative and HER2 + Breast Cancer
    Sneha Phadke
    Current Oncology Reports, 2022, 24 : 1779 - 1789
  • [49] Systemic inflammatory markers in neoadjuvant pembrolizumab therapy for triple-negative breast cancer: Prognostic insights and nomogram construction.
    Giovanardi, Filippo
    Casartelli, Chiara
    Di Cicilia, Roberto
    Bologna, Alessandra
    Gasparini, Elisa
    Moretti, Gabriella
    Esposti, Claudia Degli
    Bisagni, Giancarlo
    Pinto, Carmine
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [50] Does addition of postmastectomy radiotherapy improve outcome of patients with pT1-2, N0 triple negative breast cancer as compared to breast conservation therapy?
    Raghavan, Rajeev Kavalakara
    Ibrahim, Shabna
    Krishna, Jagathnath K. M.
    Mathew, Beela Sarah
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (05) : 1031 - 1034
12345